PRELIMINARY PROGRAM

Evening of June 13, 2007
Nobelgatan 2, Stockholm

5:30 - 7:30 pm

Welcoming Reception
The residence of U.S. Ambassador to Sweden,
H.E. Michael M. Wood
Host: Stephen Noble, Deputy Chief of Mission
Welcoming remarks
Barbro C. Ehnbom,
Chairman, Swedish-American Life Science Summit

Please do not forget to bring your ID-cards!

Gold Sponsor dinner
at Kaupthing Bank


Program June 14, 2007
Jakobsbergsgatan 24, Stockholm (Ernst & Young building)

8:30 am

Registration

9:00 am

Setting the stage
Moderator, Udayan Gupta,
WSJ Journalist and Author

9:10 am

Introductory welcoming remarks
Filippa Reinfeldt,
Health Care Commisioner, Stockholm County Council

9:20 am

Keynote address
David Brennan,
CEO, AstraZeneca

9:50 am

Biotech innovation climate - now and in the future
Niklas Prager,
CEO, Pfizer AB

10:10 am

Break

10:25 am

Panel
The big pharma challenge

Moderator: Navroze Alphonse,
Managing Partner, Pequot Capital
Panel:
Dr. Pascale Richetta,
Head of European Business Development Team,
Abbott Laboratories

Nobel Laureate Arvid Carlsson,
Professor Emeritus, Göteborg University
Dr. Johnson Lau,
Senior Advisor, Novartis
Dr. David Naveh,
Chairman, Philogene; Advisor, Teva Pharmaceutical
Peter Utterström,
Partner, Delphi & Co

Elisabeth Legnerfält,
Senior Associate, Delphi & Co

11.40 am

Coffee break

12:00 pm

Company panel presentation – “Proteomics”
Commentary: Professor Mathias Uhlén,
Royal Institute of Technology
Presenting companies:
Atlas Antibodies, Dr. Marianne Hansson, CEO 
Affibody, Dr. Lars Abrahmsén, CSO

1:00 pm

Lunch
Welcome: Torsten Lyth,
CEO, Ernst & Young AB

2.30 pm

The state of big pharma :
How we got here and where is here?

Frederick Frank,
Vice Chairman, Lehman Brothers

3:15 pm

Break

3:30 pm

Panel
Alternative financing, what works in this environment?

Moderator: Udayan Gupta,
WSJ Journalist & Author
Panel:
Les Clifford,
Life Science Practice, Ernst & Young
J. Jay Lobell,
President, Paramount BioCapital
Dr. Eugen Steiner,
Partner, HealthCap
Dr. Francesco De Rubertis,
General Partner, Index Ventures
William Gedale,
Managing General Partner, NGN Capital

4:45 pm

Concluding remarks by moderator

7.30 - 10:30 pm

Dinner Cruise sponsored by Kaupthing Bank
Host & Speaker: Robert Charpentier,
CEO, Kaupthing Bank Sverige AB


Program June 15, 2007
Jakobsbergsgatan 24, Stockholm (Ernst & Young building)

8:30 am

Coffee reception

9:00 am

Synthetic biology - a new frontier for medicine and the environment
Dr. William Haseltine,
Chairman, Haseltine Global Health

9:20 am

Panel
Success stories, what works in the US and Sweden respectively?

Moderator: Dr. Yuval Binur,
Managing General Partner, Accelerated Technologies
Panel:
Mohammed Homman,
CEO, Vironova
Hans Dahlin,
CEO, ONCOlog Medical
Lars Hellerung Christiansen,
Director Business Development, Prosidion
Ingemar Lagerlöf,
CEO, LinkMed AB

10:35 am

Coffee break

10:50 am

Company panel presentation - "CNS-diseases"
Presenting companies:
Intra-Cellular Therapies, Dr. Sharon Mates, CEO
Biovitrum, Dr. Martin Nicklasson, CEO
Neuronova, Dr. Anders Haegerstrand, CSO

12:00 am

Private equity in the medtech field. 
The Dako and Hemocue examples.

Thomas von Koch,
Senior Partner, EQT

12.25 pm

Final Remarks - Moderator

1:00 pm

Luncheon at Operakällaren (the Terrace)
Address: Operahuset, Karl XII:s torg, Stockholm
Keynote speaker: Jacob Wallenberg,
Chairman, Investor AB

Concluding remarks: Professor Jesper Tegnér,
CSO, Clinical Gene Networks


For pre-registration,

please contact our Stockholm Coordinator Astrid Lilliestråle
E-mail: astrid@swedishamericanlifescience.com
Phone: +46 (0) 70 216 90 06

or our New York Coordinator Ebba Kraemer
E-mail: ebba@swedishamericanlifescience.com
Phone: +46 (0)70 279 25 24

 
© Swedish American Life Science Summit 2007 | organizers@swedishamericanlifescience.com